Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOMILNACIPRAN Cause Persistent genital arousal disorder? 17 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Persistent genital arousal disorder have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 1.2% of all adverse event reports for LEVOMILNACIPRAN.

17
Reports of Persistent genital arousal disorder with LEVOMILNACIPRAN
1.2%
of all LEVOMILNACIPRAN reports
0
Deaths
6
Hospitalizations

How Dangerous Is Persistent genital arousal disorder From LEVOMILNACIPRAN?

Of the 17 reports, 6 (35.3%) required hospitalization.

Is Persistent genital arousal disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOMILNACIPRAN Cause?

Off label use (376) Drug ineffective (315) Gastrooesophageal reflux disease (295) Vomiting (294) Hypoaesthesia (290) Abdominal pain upper (285) Paraesthesia (282) Memory impairment (277) Blepharospasm (276) Taste disorder (276)

What Other Drugs Cause Persistent genital arousal disorder?

ALPRAZOLAM (58) SERTRALINE (50) FLUOXETINE (40) CIPROFLOXACIN (38) CLOTRIMAZOLE (38) FLUCONAZOLE (38) IBUPROFEN (38) NATAMYCIN (38) TIANEPTINE (38) ACETAMINOPHEN\CODEINE (35)

Which LEVOMILNACIPRAN Alternatives Have Lower Persistent genital arousal disorder Risk?

LEVOMILNACIPRAN vs LEVONORGESTREL LEVOMILNACIPRAN vs LEVORPHANOL LEVOMILNACIPRAN vs LEVOSIMENDAN LEVOMILNACIPRAN vs LEVOSULPIRIDE LEVOMILNACIPRAN vs LEVOTHYROXINE

Related Pages

LEVOMILNACIPRAN Full Profile All Persistent genital arousal disorder Reports All Drugs Causing Persistent genital arousal disorder LEVOMILNACIPRAN Demographics